Monday, September 21, 2009

FDA gives priority review to Auxilium�s Xiaflex

The Food and Drug Administration granted priority review status to a new drug application filed by Auxilium Pharmaceuticals Inc. for Xiaflex, an experimental treatment for Dupuytren�s contracture. (AUXL) (Source: bizjournals.com Health Care:Health Insurance headlines)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.


Read More... [Source: MedWorm: Dupuytren's Contracture - Posted by FreeAutoBlogger]

No comments:

Post a Comment